S Muhammad, T Fan, Y Hai, Y Gao, J He - Molecular Cancer, 2023 - Springer
Abstract Interleukin-2 (IL-2) and its receptor (IL-2R) are essential in orchestrating immune responses. Their function and expression in the tumor microenvironment make them …
S Bittner, T Hehlgans, M Feuerer - Trends in Immunology, 2023 - cell.com
Regulatory T (Treg) cells ensure tolerance against self-antigens, limit excessive inflammation, and support tissue repair processes. Therefore, Treg cells are currently …
PJ Cook, SJ Yang, GI Uenishi, A Grimm, SE West… - Molecular Therapy, 2023 - cell.com
Engineered T cells represent an emerging therapeutic modality. However, complex engineering strategies can present a challenge for enriching and expanding therapeutic …
P Christofi, C Pantazi, N Psatha, I Sakellari, E Yannaki… - Cancers, 2023 - mdpi.com
Simple Summary Adoptive immunotherapy has emerged as an effective alternative of mounting impact to the current standard of care in cancer, viral infections, and recently …
A Thiolat, C Pilon, P Caudana, A Moatti, NH To… - …, 2024 - ncbi.nlm.nih.gov
Modulating an immune response in opposite directions represents the holy grail in allogeneic hematopoietic stem cell transplantation (allo-HSCT) to avoid insufficient reactivity …
M Muñoz-Melero, M Biswas - Human Gene Therapy, 2024 - liebertpub.com
Adeno-associated virus (AAV) gene therapy is making rapid strides owing to its wide range of therapeutic applications. However, development of serious immune responses to the …
R Zhang, Y Zhao, X Chen, Z Zhuang, X Li… - … Reviews of Immunology, 2024 - Taylor & Francis
Regulatory T (Treg) cells are essential for maintaining self-immune tolerance. Reduced numbers or functions of Treg cells have been involved in the pathogenesis of various …
HN Khosravi, S Razi, N Rezaei - Cytokine, 2024 - Elsevier
Graft-versus-host disease (GVHD) is a significant complication following allogeneic hematopoietic cell transplantation (allo-HCT), posing substantial risks to patient survival. In …
Suppression of pathogenic immune responses is a major goal in the prevention and treatment of type 1 diabetes. Adoptive cell therapy using regulatory T cells (Tregs), a …